Delayed-Release Dimethyl Fumarate Safety and Efficacy in Pediatric Patients With Relapsing-Remitting Multiple Sclerosis

Raed Alroughani, Peter Huppke, Maria Mazurkiewicz-Beldzinska, Astrid Blaschek, Martin Valis, Gregory Aaen, Joe Pultz, Xiaomei Peng, Vanessa Beynon

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number606418
JournalFrontiers in Neurology
Volume11
DOIs
StatePublished - Jan 4 2021

ASJC Scopus Subject Areas

  • Neurology
  • Clinical Neurology

Keywords

  • dimethyl fumarate
  • efficacy
  • pediatric
  • pharmacokinetics
  • relapsing-remitting multiple sclerosis
  • safety

Cite this